| abstract |
Isolated bone formation cells for use in the treatment of a disease or bone condition associated with immunodeficiency or immunosuppression, in which said bone formation cells are osteoblasts or osteocytes and in which the bone formation cells comprise the expression of HLA-II, and in which said disease or said bone state associated with immunodeficiency or immunosuppression is osteoporosis, osteopenia, bone fragility, bone necrosis, bone fracture, bone microfractures or bone osteolysis. |